SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending sharply lower after announcing that Marvell canceled all purchase orders inherited from its acquisition of Celestial AI due to an alleged breach of confidentiality. Investors and community members are expressing significant frustration over management's handling of the disclosure, leading to widespread speculation about the company's future contracts and immediate valuation.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point for investors as they await topline Phase 3 data from the HAELO trial, which the community sees as a potential validation for their in vivo CRISPR platform. Traders are actively debating the high short interest and the stock's susceptibility to a squeeze, with many weighing the clinical promise of a functional HAE cure against the broader volatility affecting the biotech sector.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as investors weigh strong AI and automotive growth potential against near-term headwinds like supply chain constraints and cautious analyst sentiment. The stock is a primary focus for the community, which remains divided on whether the current price represents a buying opportunity or a deeper structural decline.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is experiencing significant bullish momentum driven by heavy short interest and mounting anticipation for its acquisition of Northern Data, which effectively expands its cloud and GPU infrastructure. The community is actively discussing a potential short squeeze, citing record-high short interest and strong backing from strategic partner Tether as catalysts for a potential rally.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing significant market movement driven by speculative interest in its shift toward custom AI chip design and high-performance server CPUs. Community discussions are split between euphoria over its long-term potential as an AI infrastructure backbone and intense debate regarding its valuation, with many traders actively debating the merits of aggressive shorting versus holding for a potential parabolic breakout.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant investor interest as it approaches a high-profile oral presentation of pancreatic cancer data at Digestive Disease Week, which the community views as a critical catalyst for the stock. Traders are actively accumulating shares, citing strong scientific momentum and the company's progress in expanding global clinical trials.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares is experiencing massive volatility and bullish momentum driven by a strong semiconductor sector rally, fueled by earnings optimism and ongoing AI infrastructure spending. Investors are actively debating whether the current parabolic price action signifies a sustainable super-cycle or a speculative bubble, leading to intense sentiment clashes between bullish 'diamond hands' and traders betting on a sharp mean reversion.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences is currently seeing significant investor attention driven by positive Phase 3 acne data and the potential for its FASN inhibitor denifanstat as a cornerstone MASH treatment. The community is actively debating the company's valuation, the strategic shift toward combination therapies, and the high probability of a future buyout given the surge in M&A activity within the metabolic disease sector.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

The Direxion Daily Semiconductor Bear 3X Shares (SOXS) is seeing intense volatility and record-breaking volume as traders debate whether the semiconductor sector's prolonged winning streak represents an unsustainable AI bubble or a resilient super-cycle. Community sentiment remains deeply polarized between aggressive short-sellers betting on a mean reversion and bulls who argue that relentless momentum and capital rotation into chip-related infrastructure make shorting the sector a high-risk trade.

X-Energy, Inc. operates as an energy company The firm focuses on modular nuclear reactors and fuel technology for clean energy generation. The company was founded by Kam Ghaffarian and Eben Mulder on 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-energy Inc

X-energy is generating significant investor buzz as it makes its market debut, with the community highlighting its strategic backing from major players like Amazon and Dow to address the surging energy demands of AI data centers. Traders are actively debating the company's valuation and long-term potential compared to other modular nuclear reactor peers, fueled by high initial demand and its positioning as a key player in the clean energy infrastructure space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AMTD Provides Updates to Shareholders Regarding Positive Developments on the Expected Closing of Various Transactions Amounting to ~US$328 Million

AMTD Provides Updates to Shareholders Regarding Positive Developments on the Expected Closing of Various Transactions Amounting to ~US$328 Million AMTD Provides Updates to Shareholders Regarding...

AMTD-Produced Films Achieve Cumulative Box Office of Over US$789 Million

AMTD-Produced Films Achieve Cumulative Box Office of Over US$789 Million AMTD-Produced Films Achieve Cumulative Box Office of Over US$789 Million PR Newswire PARIS and NEW YORK and LONDON, April 10...

AMTD IDEA Group Announces Dividend Plan to Distribute Shares of Listed Subsidiaries

AMTD IDEA Group Announces Dividend Plan to Distribute Shares of Listed Subsidiaries AMTD IDEA Group Announces Dividend Plan to Distribute Shares of Listed Subsidiaries PR Newswire PARIS and NEW YORK...

AMTD IDEA Group's Controlling Shareholder, Directors and Executive Officers Enter into Voluntary Lock-up on Holdings

AMTD IDEA Group's Controlling Shareholder, Directors and Executive Officers Enter into Voluntary Lock-up on Holdings AMTD IDEA Group's Controlling Shareholder, Directors and Executive Officers Enter into Voluntary Lock-up on Holdings PR Newswire PARIS, NEW YORK and SINGAPORE, April 8, 2026 PARIS...

Dr. Feridun Hamdullahpur, Chairman of AMTD Group, Appointed to the Global Strategic Advisory Board of HKUST (GZ)

Dr. Feridun Hamdullahpur, Chairman of AMTD Group, Appointed to the Global Strategic Advisory Board of HKUST (GZ) Dr. Feridun Hamdullahpur, Chairman of AMTD Group, Appointed to the Global Strategic...

Dr. Calvin Choi, Founder of AMTD IDEA, ReAppointed as the Chief President of the Hong Kong Island Youth United Association

Dr. Calvin Choi, Founder of AMTD IDEA, ReAppointed as the Chief President of the Hong Kong Island Youth United Association Dr. Calvin Choi, Founder of AMTD IDEA, ReAppointed as the Chief President of...

AMTD owned Global Art Media - The Art Newspaper Officially Registered in Hong Kong with the Government and Launches Its Inaugural Hong Kong Edition

AMTD owned Global Art Media - The Art Newspaper Officially Registered in Hong Kong with the Government and Launches Its Inaugural Hong Kong Edition AMTD owned Global Art Media - The Art Newspaper...

TGE's Latest Film "Scare Out" Surpasses US$190 Million at the Global Box Office

TGE's Latest Film 'Scare Out' Surpasses US$190 Million at the Global Box Office TGE's Latest Film 'Scare Out' Surpasses US$190 Million at the Global Box Office PR Newswire PARIS, NEW YORK and LONDON...

AMTD Reached Deals on the Acquisition of a London Office Tower, in Conjunction with Amendment to Terms of Acquisition of the London Hornsey Town Hall Project, with Total Transaction Value at US$87.7 Million

AMTD Reached Deals on the Acquisition of a London Office Tower, in Conjunction with Amendment to Terms of Acquisition of the London Hornsey Town Hall Project, with Total Transaction Value at US$87.7...

AMTD Digital's Subsidiary TGE Announces Successful Completion of Acquisition of the New York Tribeca Hotel at US$69 Million

AMTD Digital's Subsidiary TGE Announces Successful Completion of Acquisition of the New York Tribeca Hotel at US$69 Million AMTD Digital's Subsidiary TGE Announces Successful Completion of...

AMTD IDEA Group is an investment holding company, which engages in the provision of capital market solutions. It operates through the following segments: Capital Market Solutions; Digital Solutions and Other Services; Media and Entertainment Services; Hotel Operations, Hospitality, and VIP (very important person) Services; and Strategic Investments. The Capital Market Solutions segment includes underwriting commission, brokerage, handling, and financial advisory, and asset management services. The Digital Solutions and Other Services segment involves insurance brokerage services. The Media and Entertainment Services focuses licensing and marketing of fashion, arts and luxury magazines, and advertising services. The Hotel Operations, Hospitality, and VIP Services segment refers to accommodations and other ancillary services to guests. The company was founded by Chi Kin Choi on February 4, 2019 and is headquartered in Paris, France.

AMTD
AMTD IDEA Group - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AMTD News

AMTDAMTD IDEA Group - ADR